Trademark: 76408112
Word
MOLMED
Status Date
Monday, February 9, 2015
Registration Number
2921934
Registration Date
Tuesday, February 1, 2005
Filing Date
Monday, May 13, 2002
Published for Opposition
Tuesday, November 9, 2004
5 Cells for medical or clinical use, namely for use in respect to heamatopietic malignancies, namely HIV replication and solid tumors
42 Scientific research in the fields of HIV and cancer
Color is not claimed as a feature of the mark.
Feb 9, 2015
Notice Of Acceptance Of Sec. 8 & 9 - Mailed
Feb 9, 2015
Registered And Renewed (First Renewal - 10 Yrs)
Feb 9, 2015
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Feb 6, 2015
Case Assigned To Post Registration Paralegal
Jan 23, 2015
Teas Section 8 & 9 Received
Jan 12, 2011
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jan 11, 2011
Case Assigned To Post Registration Paralegal
Dec 22, 2010
Teas Section 8 & 15 Received
Feb 1, 2005
Registered-Principal Register
Nov 9, 2004
Published For Opposition
Oct 20, 2004
Notice Of Publication
Sep 9, 2004
Law Office Publication Review Completed
Aug 26, 2004
Assigned To Lie
Aug 9, 2004
Approved For Pub - Principal Register
Apr 26, 2004
Correspondence Received In Law Office
Apr 26, 2004
Paper Received
Feb 23, 2004
Case File In Ticrs
Aug 25, 2003
Letter Of Suspension Mailed
Aug 4, 2003
Final Refusal Mailed
Feb 6, 2003
Sec. 1(B) Claim Deleted
Feb 6, 2003
Correspondence Received In Law Office
Feb 6, 2003
Paper Received
Nov 4, 2002
Letter Of Suspension Mailed
Nov 4, 2002
Previous Allowance Count Withdrawn
Oct 1, 2002
Approved For Pub - Principal Register
Sep 30, 2002
Examiners Amendment Mailed
Sep 9, 2002
Non-Final Action Mailed
Sep 4, 2002
Assigned To Examiner
Aug 1, 2002
Paper Received
Trademark Alertz updated from USPTO on 2030-01-24
